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Abstract
Background: Intestinal obstruction is a poorly recognized and probably underreported complication of
strongyloidiasis. We present herein an unusual case, of complete duodenal obstruction caused by S. stercoralis.
Methods: A systematic review of the literature examining the clinical course, diagnostic methods, and outcome of
this rare complication of strongyloidiasis was performed.
Results: A 42-year-old woman presented with a 5-month history of abdominal pain, vomit, and weight loss. An
abdominal CT scan showed an obstruction of the third part of the duodenum. Segmental intestinal resection was
carried out and histopathology examination revealed heavy Strongyloides stercoralis infestation. Duodenal
obstruction is a rare complication of S. stercoralis infection, with only 8 cases described in the literature since 1970.
Most of the patients are males, middle-aged, and the diagnosis was made by duodenal aspirate/biopsy, or analysis
of surgical specimen.
Conclusions: Duodenal obstruction is an unusual, but potential fatal, complication of S. stercoralis infection. The
large spectrum of clinical manifestation and lack of classic clinical syndrome make the final diagnosis of
strongyloidiasis extremely difficult. A high index of suspicion, mainly in patients from endemic areas, is needed for
correct and early diagnosis of this uncommon presentation of Strogyloides stercoralis enteritis.
Background
Strongyloidiasis is a parasitic disease, caused by a nema-
tode helminth, Strongyloides stercoralis. The true preva-
lence of S. stercoralis is likely underestimated because
infection is often subclinical [1-3]. Currently, an esti-
mated 100 million people are infected worldwide in
more than 70 countries. Strongyloidiasis is endemic in
Southeast Asia, Latin America, Sub-Saharan Africa, and
parts of the southeastern United States [3-6]. Typically,
the infection is asymptomatic or manifest as vague and
unspecific gastrointestinal symptoms. However, dissemi-
nated infestation of infective larvae is associated with
high mortality rates in immunocompromised patients
[3,7].
Intestinal obstruction is a poorly recognized and prob-
ably underreported complication of strongyloidiasis.
Herein, we report an unusual case, of complete duode-
nal obstruction caused by S. stercoralis. Additionally, we
performed a systematic review of the literature examin-
ing the clinical course, diagnostic methods, management
and outcome of this rare, but potential fatal complica-
tion of S. stercoralis infection.
Methods
A review of literature was performed using the MED-
LINE database in order to identify articles of duodenal
obstruction caused by Strongyloides stercolaris. Inclusion
was limited to cases reported in adults, and published in
the English language since 1970. All the articles were
systematically reviewed and only cases of confirmed
duodenal obstruction were included in this report.
Case presentation
A 42-year-old woman presented with a 5-month history
of recurrent abdominal pain, nausea, post-prandial
vomiting, intermittent diarrhea, and a 20 Kg (44 lb)
weight loss. Her past medical history was unremarkable,
except for an admission for pneumonia in the past year.
On physical examination the patient was in poor clinical
condition, malnourished, afebrile, with a blood pressure
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respiratory rate of 24 breaths per minute. No lymphade-
nophaty was found. The lungs were clear and the heart
was normal on auscultation. Abdominal examination
revealed epigastric distention, without guarding or
rebound tenderness. The spleen and liver were not pal-
pated and a mild pedal edema was observed.
Stools tested for occult blood were positive, and nega-
tive for ova and parasites. Laboratory evaluation revealed
a hematocrit of 39%, white blood cell count of 14.9 ×
10
3/L (bands 8%, neutrophils 73%, lynphocytes 12%, and
eosinophils 0%), and platelet count of 600 × 10
3/μL.
Total serum protein and albumin levels were 2.9 g/dL
and 1.2 g/dL, respectively. Serum creatinine was 2.5 mg/
dL, BUN 118 mg/dL, and potassium 2.8 mMol/L. Liver
function tests, amylase and lipase were within normal
limits. She had a positive serology for toxoplasmosis
(IgM antibody), but negative for HIV, and HTLV-1.
A central line was established and fluid replacement
was started. Broad-spectrum antibiotics were initiated
for a possible intraabdominal infection/sepsis. An
abdominal computed tomographic scan showed a
marked gastric and duodenal distension, with a possible
point of obstruction of the third part of the duodenum
(Figure 1A). A nasogastric tube was placed for gastric
decompression. Upper endoscopy was nondiagnostic
due to a marked retention of alimentary residue in the
stomach.
At this point we decided to start the patient on total
parenteral nutrition and repeat the upper endoscopy in
48 hours. Despite clinical support, 24 hours after admis-
sion, the patient presented a significant worsening of the
abdominal pain, fever, increasing white blood cell count,
and intermittent hypotension requiring additional intra-
venous fluid bolus. Based on the abdominal CT findings,
we suspected of the presence of a complicated submu-
cosal duodenal tumor, such as a primary intestinal lym-
phoma or gastrointestinal stromal tumor, and decided
to take the patient to the operating room.
She underwent an exploratory laparotomy that showed
diffuse thickening and edema of the proximal small
bowel, and a severe stenosis of the third part of the duo-
denum. Resection of the narrowed segment was carried
out and an end-to-end duodenojejunostomy was per-
formed. The resected specimen showed a severe inflam-
matory process, associated with mucosal ulceration and
hemorrhage (Figure 1B). Histopathology examination
revealed severe inflammation of the intestinal wall with
heavy infestation of Strongyloides stercoralis (Figures 2A,
and 2B). The patient was sent to the intensive care, anti-
biotics were continued, and treatment for disseminated
strongyloidiasis with a combination therapy of ivermec-
tin at a dose of 200 mcg/kg daily and albendazole 400
mg twice a day was started. Despite adequate clinical
support, the patient died of septic shock seven days
after exploratory laparotomy.
Discussion
Strongyloidiasis is a common intestinal infection caused
by two species of the nematode Strongyloides. The most
common and clinically important pathogenic species in
humans is Strongyloides stercoralis. The other specie,
Strongyloides fuelleborni, is found sporadically in Africa
and may produce limited infections in humans [3,8].
Strongyloidiasis was first described in 1876, in French
colonial troops suffering from diarrhea in Vietnam [9].
T h ec o m p l e t ee l u c i d a t i o no ft h ep a r a s i t e ’s life cycle
occurred 50 years after its identification. This fact is
probably related to the unique and complex life cycle of
the parasite. Strongyloides stercoralis larvae exist in two
forms: free-living rhabditiform and filariform infective
larvae. The cycle starts with the infectious filariform lar-
vae penetrating the skin and traveling via lymphatics or
bloodstream to the lungs. After penetrating in the
alveoli the larvae continue to migrate up to the airways
until they are swallowed. In the duodenum and proxi-
mal jejunum the larvae mature into adult females which
live threaded in the intestinal mucosa. The larvae can
Figure 1 (A) Abdominal CT scan showing a large dilation of
stomach (S) and duodenum (D).( B) Severe inflammation, mucosal
hemorrhage and focal ulcerations of duodenum and proximal
jejunum. Black arrows show the point of obstruction.
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(i.e., asexual reproduction where development of
embryos occurs without fertilization by a male). Once
these eggs hatch, rhabditiform larvae are released. These
larvae can either passed in the stools, continuing the
soil based cycle, or can cause autoinfection. The autoin-
fection occurs when the rhabditiform larvae prematurely
become the infective filariform larvae in the intestinal
lumen, and penetrate in the intestinal mucosa or peria-
nal skin (internal and external autoinfection, respec-
tively). In either case the infective larvae migrate to the
lungs and restart the cycle previously described [1,3,7].
The autoinfection phenomenon allows S. stercoralis to
persist and replicate within a host for decades, with the
longest reported period being 65 years [10].
The term “disseminated disease” is used to define
when the infective larvae migrate, from the intestine, in
massive numbers not only to the lungs but to other
organs not involved in the normal helminthic life cycle.
In disseminated strongyloidiasis, the mortality rate can
be as high as 70-90% [3]. Several risk factors are
associated with the development of disseminated stron-
gyloidiasis, including (1) immune deficiency, (2) hemato-
logic malignacy, (3) steroids administration, (4) HTLV-1
infection, (5) chronic alcoholism, (6) renal failure, (7)
transplantation, among others [11]. In disseminated dis-
ease, translocation of enteric bacteria may occur, leading
to Gram-negative sepsis and/or meningitis. The enteric
microorganism can either enter the circulation through
intestinal ulcers or be carried by the infective filariform
larvae.
Approximately, half of Strongyloides infections are
asymptomatic [1,3]. Clinical presentation is extremely
variable reflecting the complex life cycle of the parasite.
When symptoms develop, gastrointestinal complaints
are common. Symptoms are vague and nonspecific and
include anorexia, nausea, vomiting, weight loss, abdom-
inal pain, flatulence, and diarrhea. Less frequently,
malabsorption syndromes, paralytic ileus, intestinal
obstruction and gastrointestinal bleeding, may occur
[1-3]. Pulmonary symptoms are rare in uncomplicated
strongyloidiasis, but cough and wheezing may be part of
initial presentation (Löffler’s syndrome). In disseminated
disease respiratory symptoms become more prominent
and include dyspnea, tachypnea, pleuritic pain, pleural
effusion, and hemoptysis [1,2,6]. Larva currens (racing
larvae) is the pathognomonic cutaneus manifestation of
Strongyloidis infection that usually occurs during an
external autoinfection episode. The serpiginous urticarial
rash is caused by rapid (approximatelly 15 cm/h) mov-
ing of Strongyloides stercoralis larvae from the anal area
down the upper thighs [3,12].
Duodenal obstruction is an extremely rare complica-
tion of strongyloidiasis, with eight cases reported in the
medical literature. Table 1 summarizes all the reported
cases of duodenal obstruction caused by Strongyloides
stercolaris since 1970 [9,13-18]. Two mechanisms have
been implicated in the duodenal obstruction due to S.
stercoralis. First, the obstruction would be related to a
severe mucosal edema and inflammation with significant
narrowing of duodenal lumen. Second, an extrinsic
compression of the duodenum by the superior mesen-
teric neurovascular bundle could be responsible for the
obstructive symptoms. Several mechanisms are proposed
to explicate the extrinsic duodenal compression (i.e.
superior mesenteric artery/Wilkie’s Syndrome) in
patients with strongyloidiasis, including severe weight
loss, duodenal distention, mesenteric lymphatic dilation,
and increase in the diameter of superior mesenteric ves-
sels [15,16,19].
Paralytic ileus is also a potential complication of S.
stercolaris hyperinfection [7,11,20-23]. In a recent
review, Yoshida et al. have reported 25 cases of Strongy-
loides-related ileus [11]. Most of the patients were males
(60%) and middle-aged, findings similar to patients with
Figure 2 Histopathological examination of the duodenal
mucosa (hematoxylin-eosin staining). (A) Cross-sections of
Strongyloides larvae within the intestinal mucosa (arrows) associated
with diffuse eosinophil and plasma cell infiltration. (B) Higher
magnification showing a female Strongyloides stercolaris ovaries
(arrows) and intestine (white arrow). A longitudinal section of S.
stercolaris larva can also be observed (double arrow).
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in the literature, it seems that obstructive gastrointest-
inal symptoms are more common in this specific group
of patients, since the infection has no predilection for
either sex or age.
Strongyloidiasis is usually associated with anemia,
hypocholesterolemia and hypoalbuminemia. Eosinophilia
is an inconsistent finding, present in up to 35% during
the acute phase, and less frequent in patients with
chronic or disseminated disease. Most patients with
duodenal obstruction presented low eosinophil count
indicating a chronic infection. Eosinopenia and low IgE
level have been associated with a poor prognosis, in
patients with disseminated disease [3,11].
Duodenal obstruction may be caused by different dis-
eases, including tuberculosis, primary intestinal lym-
phoma, Crohn’s disease, eosinophilic gastroenteritis and
gastrointestinal stromal tumor. Despite extensive preo-
perative work-up, three out of the nine cases presented
in Table 1, the diagnosis was made after exploratory
laparotomy. Therefore, a high index of suspicion is
essential for correct diagnosis of Strongyloides-related
duodenal obstruction. The diagnosis of strongyloidiasis
may be confirmed by the presence of the larvae in the
stools. This is an easy performed, broadly available and
inexpensive method for detection of the parasite. How-
ever, stool examination is relatively insensitive, and diag-
nostic yield of a single specimen is approximately 30%.
The sensitivity of fecal smear could be increased to up
to 60%, if five or more stool samples are examined [24].
Of note, S. stercoralis i st h eo n l yh e l m i n t ht h a ts e c r e t e s
larvae in the stools. Thus, the presence of eggs in the
fecal smear is unlikely.
Other methods such as duodenal aspirate or biopsy
are more invasive therefore less desirable. Nevertheless,
it has been shown that the examination of a duodenal
aspirate for ova and larvae is the most sensitive diagnos-
tic procedure, with a false-negative frequency of less
than 10% [24,25]. Endoscopic findings include duodenal
mucosal edema, erythema, hemorrhagic spots, ulcera-
tions, and in some cases megaduodenum. Duodenal
white villi is also a common endoscopic feature, and
should alert the physician for the diagnosis of strongy-
loidiasis [25,26]. Recently, Kishimoto et al. showed that
the S. stercoralis larvae identification in duodenal biop-
sies is feasible in 71% of cases [27]. In eight out of the
nine cases presented in Table 1, the diagnosis was made
by duodenal aspirate/biopsy, or analysis of surgical spe-
cimen. These findings confirmed the poor reliability of
stool analysis for the parasite identification
In cases of disseminated infection, the parasite can be
also identified in sputum, broncho-alveolar lavage, cere-
brospinal fluid, skin, urine, and ascites [7]. Serology
tests are indicated when the infection is suspected and
the S. stercoralis cannot be demonstrated by the stan-
dard diagnostic evaluation. Although, indirect hemmag-
glutination (IHA) and indirect fluorescent antibody
(IFA) test have been used, enzyme-linked immunosor-
bent assay (ELISA) is currently recommended because
of its greater sensitivity [8,28,29]. Despite its high speci-
ficity and sensitivity, immunodiagnostic tests have cer-
tain limitations, including: (1) variable reliability in
Table 1 Literature review of duodenal obstruction caused by Strongyloides stercoralis infection (1970-2010)
Author Year Age Gender Country Associated
disease
WBC/
eosinophils
Surgery Diagnosis Treatment Outcome
Cohen &
Spry
13
1979 40 M England lymphoma 16.500/4% SB resection DA, EGD+bx thiabendazole * Dead
Zyngier et al.
14 1983 30 M Brazil no NR/0% gastrojejunostomy GA, sputum thiabendazole † Alive
Lee & Terry
15 1989 15 M Jamaica no 4.400/NR no stool analysis thiabendazole ‡ Alive
1989 19 F Jamaica no 10.000/NR no DA thiabendazole Alive
Friedenberg et
al.
16
1999 40 M USA HTLV-1
infection
35.500/1% no EGD+bx thiabendazole Dead
Harish et al.
9 2005 45 M India no 12.000/14% no DA, EGD+bx ivermectin Alive
Suvarna et
al.
17
2005 70 M India no 11.000/(220/
μL)
no EGD+bx ivermectin # Alive
Juchems et
al.
18
2008 63 M Germany no 10.500/NR partial
gastrectomy
surgical
specimen
ivermectin Alive
Current case 2010 42 F Brazil no 14.900/0% duodenal
resection
surgical
specimen
ivermectin +
albendazole
Dead
NR, not reported; WBC, white blood cell count; DA, duodenal aspirate; GA, gastric aspirate; EGD, esophagogastroduodenoscopy; SB small bowel; bx, biopsy; HTLV-
1, Human T-lymphotropic virus Type I
* small bowel resection after medical treatment for strongyloidiasis showed poorly differentiate small bowel lymphoma
† patient underwent to a gastrojejunostomy; diagnosis was made after surgery by EGD + gastric aspirate
‡ patient presented new episode of duodenal obstruction 6 years after the initial treatment/recurrent strongyloidiasis
# initially treated with albendazole without success.
Cruz et al. World Journal of Emergency Surgery 2010, 5:23
http://www.wjes.org/content/5/1/23
Page 4 of 6different commercial kits available, (2) falsely negative
results in immunocompromised hosts, (3) the presence
of anti-strongyloides antibody for a long period of time,
even after successful treatment, and (4) falsely positive
results due to cross-reactions with other parasitic infec-
tions such as filariasis and acute schistosomiasis [3,8].
Imaging studies are nonspecific. However, radiological
abnormalities restricted to the duodenum and proximal
jejunum, on CT scans and upper gastrointestinal series,
should alert the surgeon to the possibility of strongyloi-
diasis. A unique radiographic feature of strongyloidiasis
is the reflux of oral contrast into the biliary tree, possi-
bly due to an incompetent sphincter of Oddi caused by
severe inflammation of the duodenal wall [30].
Medical treatment should be achieved even in the
absence of symptoms, in order to avoid the dissemina-
tion of the parasite and minimize the risk of develop-
ment hyperinfection syndrome. The drug of choice for
treatment of strongyloidiasis is ivermectin given at a
dose of 200 mcg/kg of body weight daily for at least
2 days [3,8,31]. In cases of disseminated disease it may
be necessary to prolong or repeat therapy. Albendazole
and thiabendazole, are equivalent to ivermectin in effi-
cacy. However, thiabendazole is associated with frequent
and severe side effects, and has not been longer recom-
mended for systemic infection in HIV-patients [7]. Due
to a critical condition of our patient we decided to use a
combination therapy of albendazole and ivermectin.
This therapeutic strategy has been recommended for the
treatment of disseminated strongyloidiasis with good
results [3,8,25].
In patients who are not able to tolerate oral treatment,
rectal administration of ivermectin or thiabendazole has
been suggested [32,33]. However, recent reports have
shown that serum ivermectin concentration is very low
after rectal administration in patients sustaining paraly-
tic ileus or intestinal obstruction [34,35]. No parenteral
preparation of these anthelmintics is available for use in
humans, although subcutaneous veterinary ivermectin
has been utilized successfully in the treatment of stron-
gyloidiasis unresponsive to standard oral therapy or
when enteral administration is not feasible [34-36].
Thus, further studies assessing safety, efficacy and phar-
macokinetics of parenteral ivermectin are needed in
order improve the treatment and outcome of patients
sustaining this unusual complication of Strongyloides
stercoralis hyperinfection.
Conclusion
In summary, duodenal obstruction is a rare, but poten-
tial fatal, complication of S. stercoralis infection. The
large spectrum of clinical manifestation and lack of clas-
sic clinical syndrome make the final diagnosis of stron-
gyloidiasis extremely difficult. Therefore a high index of
suspicion, mainly in patients from endemic areas, is
needed for correct and early diagnosis of this uncom-
mon complication of Strogyloides stercoralis infection.
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